World Tuberculosis Day 2015
On March 24th 1882, Dr Robert Koch announced that he had discovered the cause of tuberculosis (TB). 24th March is 'World Tuberculosis Day' - an opportunity to raise awareness about the burden of TB worldwide.
Although not that common in the UK (there were 7,892 recorded cases in the UK in 2013), TB is still a big problem in other parts of the world. NDM spoke to Professor Guy Thwaites, Director of the Oxford Clinical Research Unit in Vietnam, about the situation in South-east Asia and the ongoing research at OUCRU in to eradicating the disease and improving patient outcomes.
Q: How common is tuberculosis in South-east Asia compared with the rest of the world?
Guy Thwaites: TB is very common in South-east Asia, especially in Myanmar, Cambodia and Vietnam. However, although the incidence of new TB cases is lower than in many parts of sub-Saharan Africa, the very large populations in the region means that moderately high incidence rates translate to very large numbers of people with the disease. For example, in Vietnam each year (with a population of 90 million) there are more than 100,000 cases notified and treated.
Q: What challenges need to be overcome to improve patient outcomes?
GT: There are three major challenges and they are not unique to South-east Asia. The first challenge is drug resistance. We have estimated that there are probably around 5000 new cases of multi-drug resistant TB in Vietnam each year. Only around 1000 of these are currently being detected and treated. Treating these cases is difficult and the outcomes for people with drug-resistant TB are much worse than for people who have drug susceptible disease. This is a major problem, especially when these missed cases will be responsible for on-going transmission of multi-drug resistant TB to other people.
The second challenge is organisational. Detecting patients quickly and getting them to take 6 months of treatment (or in cases of multi-drug resistant TB at least 18 months of treatment) is difficult and requires considerable co-ordination and support on behalf of the healthcare services. In resource-limited countries this is very challenging. The situation is not helped in Vietnam by increasing numbers of patients opting to start treatment in the private healthcare system, where drug regimens are unregulated and often inadequate, exposing the patient to greater risks of treatment failures and the development of drug resistance.
The third major challenge is a scientific one: how can we shorten TB treatment to 2 months or less such that adherence would be improved and the organisational strain on TB treatment programmes alleviated? Why TB takes such a long time to cure is still a mystery, especially when we know that 90% of the bacteria are killed within the first 14 days of treatment. If we knew why the last 10% of bacteria took another 5.5 months to kill we would probably be very much closer to developing very much shorter treatment regimens.
Q: What research is OUCRU doing to try and combat tuberculosis?
GT: OUCRU has worked for 15 years in trying to improve outcomes from some of the most severe forms of tuberculosis and, in particular, tuberculous meningitis. We have performed a series of clinical trials, addressing the role of adjunctive dexamethasone, the timing of anti-retroviral drugs, and most recently whether the use of higher doses of TB drugs improves outcomes. We will continue to work on tuberculous meningitis because it kills or disables around 50% of sufferers, but it has also allowed us to make some important observations of the pathophysiology of the disease which may have implications for the clinical management of all forms of TB. In the light of some of our recent findings in TB meningitis – in particular the genetic control of the inflammatory response to the infection - we will extend our work into pulmonary tuberculosis. We want to better understand the determinants of treatment failure and, with the Mahidol-Oxford Research Unit in Thailand, we want to set up a network of sites across SE Asia that would be capable of performing large, pragmatic randomised controlled trials. There has been an increase in clinical tuberculosis research worldwide over the last decade, but most of the clinical trial data comes from Africa. Trials networks are required in Asia and we look to lead the development of these through the Oxford-linked centres in the region.
Q: Do you think that tuberculosis will ever be eradicated in our lifetime?
GT: I am an almost pathological optimist, but no - I do not think we will eradicate the disease in my lifetime. In might be possible in my children's lifetime (my youngest daughter is 12) but I wouldn’t put more than 30,000 Vietnamese Dong (~£1) on it. The reason for my pessimism? The ability of the bacteria to lie ‘latent’ in our bodies without causing any disease for many years. It is estimated that around 1/3rd of all the world is ‘latently’ infected with TB. However, only around 10% of these people will actually get symptoms and disease and it is not yet possible to predict who these will be with any accuracy. So, if we were going to eradicate TB by the end of my lifetime we would not only need to successfully treat every case of active TB on the planet, but also the more than 2 billion people with latent infection too - to ensure that the bacteria won’t just spring back into life in someone when it is least expected! A good vaccine would help, but we are still a long way off having one. Therefore, I think TB clinicians and researchers will still be very busy for many decades to come.
- Institutes, centres & units
- NDM Strategic
- Contact
- Public Involvement
-
News
- Using management thinking to fight the superbug crisis
- Getting rid of malaria possible, if we try something new, say experts
- Success for NDM project awarded Public Engagement Seed Funding
- Flu vaccine spinout secures a further £20m in funding
- Global health needs demand new approach to drug discovery
- Building international partnerships to tackle disease
- Nepali pilgrims to Gosaikunda video
- China Vice Premier in Oxford for signing of research collaboration
- Largest genetic study of mosquitoes reveals spread of insecticide resistance across Africa
- Researchers attack Mekong malaria superbug on multiple fronts
- Kevin Marsh Wins 2017 Drexel Prize in Infectious Disease
- Prof Simon Leedham wins CRUK Prize
- Oxford-Mahidol collaboration shortlisted for Newton Prize
- BioBeat unveils 2017’s 50 Movers and Shakers
- Study raises possibility of vaccines against allergies and Alzheimer’s
- Celebrating Oxfordshire brightest science stars
- New structural insights accelerate drug discovery in the ubiquitin system for cancer therapy
- National Academy of Medicine elects Nick White as international member
- New collaboration to tackle superbugs
- 115 years of malaria in Africa
- Oxford and the mosquito
- World-first trial for universal flu vaccine
- New typhoid vaccine offers hope of protection for children
- Prof Emily Chan wins the 2017 UGC Teaching Award
- The Medical Research Foundation to fund first national PhD Training Programme to tackle antimicrobial resistance
- Superbug’s spread to Vietnam threatens malaria control
- New NDM Professors
- Establishing the Africa Oxford Initiative
- Combining cultures
- Experts urge rethink of ‘outdated’ asthma categorisation
- International research network nominated for ‘Oscar of higher education’
- Oxford University claims top world ranking for second year
- Bash the Bug! Winner of 2017 NIHR Let’s Get Digital competition
- Scientists discover unknown virus in ‘throwaway’ DNA
- Improved home designs may fight malaria in Africa
- Antibodies may reveal timing of previous influenza infection
- Discovery Award to decode TB DNA
- Is it time to drop the ‘complete the course’ message for antibiotics?
- World Hepatitis Day
- Call for Abstract MVVR5 2017
- Breaking boundaries in our DNA
- Quick test can predict anaemia in malaria patients treated with artemisinins
- New Year's Honours 2018
- What's behind the sudden rise in measles deaths in Europe?
- Cancer hijacks natural cell process to survive
- Mahidol begins Asia’s first study of RTS,S malaria vaccine
- Oxford one of six sites to receive funding for health data science
- Five surprising things DNA has revealed about our ancestors
- OUMNH Exhibition based on centre research
- Could aspirin be used to treat tuberculous meningitis?
- ALS Reproducible Antibody Platform launched
- Cultural barriers to tackling the superbug crisis
- ALERRT epidemic research network launched in sub-Saharan Africa
- Making malaria visible
- Women in STM
- Female body shape gene may increase risk of type 2 diabetes
- The town that breeds resistance to Malaria drugs
- Can you cure HIV?
- Professor Dominic Kwiatkowski joins the Fellowship of the Royal Society
- Prof Vincenzo Cerundolo elected Fellow of the Royal Society
- NDM Researchers elected as Fellows of the Academy of Medical Science
- Using management thinking to fight the superbug crisis
- FORMA Therapeutics and the University of Oxford Announce Multi-Year Cross-Border Collaboration
- HIV researchers create Chelsea garden to raise awareness of disease stigma
- China Vice Premier and Minster of National Health Commission visit to CTI Beijing
- Oxford overtakes Cambridge for first time in QS world rankings
- New age-based regimen for single low-dose primaquine to block malaria transmission
- Rosalind Franklin Institute will 'transform' life sciences research through disruptive technologies
- Big Data Institute wins a 2018 RIBA South Award
- NDM Researcher gets £1m boost to study immunology of asthma
- Professor Rose McGready awarded Alumni Award for Service to Humanity
- Researchers explore malaria vaccines and antibiotic resistance at RS Summer Science Exhibition
- Trial of ‘kick and kill’ approach to HIV cure leaves puzzles to be solved
- NDM Researcher recognised for major contribution in clinical sciences
- ASHG Honours Professor Cecilia Lindgren with Mentorship Award
- New NDM Professors
- Prof Helen McShane appointed as new Director of Oxford Biomedical Research Centre
- Detailed map of colon cells in health and disease
- UK-led study marks shift towards genetic era in tackling TB
- Tales of treatment, of modernity and tradition, and of global health crisis
- Faith Osier TED talk
- 'Tantalising and exciting’: UK Biobank genetics opens the door to a new era of health research
- Oxford secures £17.5 million to lead national programmes in AI to improve healthcare
- New grant to study the role of immune cells in lung regeneration
- Dr Ross Chapman welcomed as EMBO Young Investigator
- New vaccines centre to protect UK from pandemic threats
- Professor Sir David Weatherall: 1933-2018
- Congratulations to Jeremy Farrar, knighted in the New Year's Honours 2019
- Watch Prof Peter Donnelly speak at Royal Society AI event
- NDM's Translational Gastroenterology Unit awarded a CRUK Primer grant of £100,000
- ISARIC awarded £4.5 million to tackle the global threat of epidemic infectious diseases
- Tracking resistance results presented at Westminster
- The battle within- new animation on the immune system
- Vaccine developed to treat osteoarthritic pain
- World Malaria Day 2019
- Faces of malaria
- Mads Gyrd-Hansen awarded Wellcome Trust Senior Research Fellowship renewal
- NDM Researchers elected Fellows of the Academy of Medical Sciences
- Oxford academics recognised in 2019 Queen’s Birthday Honours
- Ross Chapman awarded 2019 Lister Prize
- New maps could show how to beat malaria
- Vice-Chancellor’s Choice Award for Public Engagement with Research
- New malaria parasite mutations cause alarming antimalarial drug failures in Southeast Asia
- New NDM Professors
- The RECOVERY Trial has recruited 1000 patients in 15 days
- Controlling coronavirus transmission using a mobile app to trace close proximity contacts
- Digital contact tracing can slow or even stop coronavirus transmission and ease us out of lockdown
- Oxford's COVID-19 research receives government funding
- First patients enrolled in new clinical trial of possible COVID-19 treatments
- Covid-19: how effective is social distancing?
- Infectious disease experts provide evidence for a coronavirus mobile app for instant contact tracing
- Sir Peter Ratcliffe on BBC Radio 4 - The Life Scientific
- Wellcome Investigator Awards
- International research consortium activates clinical study for novel coronavirus in England and Scotland
- Professor Vincenzo Cerundolo FRS 1959-2020
- Oxford University awarded €56 million in European Research Council funding
- Oxford named best for medicine for ninth consecutive year
- NDM DPhil Graduate Student Prizes 2019
- Modelling research aims to inform new WHO roadmap for neglected tropical diseases
- Woman of the Future award for Science
- Obesity now linked to broader range of leading killers, with women and men showing different patterns of risk
- Medical Sciences and climate breakdown: time to move beyond evidence
- Oxford Tropical Medicine awarded two RSTMH medals
- Oxford ranked world’s best university for fourth year running
- Landmark partnership announced for development of COVID-19 vaccine
- Chan Zuckerberg Initiative awards funding to Oxford team to support inflammation research
- Oxford University Coronavirus Research Webinar
- New study reveals Oxford coronavirus vaccine produces strong immune response
- The Duke of Cambridge visits Oxford Vaccine Centre
- The Ludwig Institute for Cancer Research welcomes cancer epigenetics researcher Yang Shi
- New NDM titles awarded
- Future of Oxford professorship in vaccinology secured with £3.5 million gift
- Oxford study suggests notable decline in coronavirus cases and R rate on Isle of Wight after launch of the test and trace programme
- Dave Stuart awarded The Gabor Medal 2020
- Latest version of COVID-19 contact tracing app ready for testing on the Isle of Wight and Newham, London
- Collaboration with Magdalen College outreach to run remote work experience
- Persistent immune memory of COVID-19 found in recovered patient T cells
- New research shows tracing apps can save lives at all levels of uptake
- Evaluation of LamPORE rapid tests for Covid-19 show high levels of diagnostic sensitivity
- Comparison of five tests used to detect COVID-19 antibodies shows Siemens and Oxford assays met regulatory targets
- Oxford’s OpenABM-Covid19 mathematical model helps to control the coronavirus epidemic
- Oxford’s OpenABM-Covid19 mathematical model helps to control the coronavirus epidemic
- The University of Oxford and King Abdulaziz University (KAU) have partnered to create a new Centre for Artificial Intelligence and Precision Medicine.
- Professor Sarah Walker, a Professor of Medical Statistics and Epidemiology in NDM and the Oxford BRC’s Co-theme Lead for Antimicrobial Resistance and Modernising Microbiology, is to receive an OBE.
- Simon Leedham appointed as Professor of Molecular and Population Genetics
- Two vital research programmes taking place at the university of Oxford may hold the key to understanding the immunity of recovered Covid-19 patients.
- New partnership with The Alan Turing Institute and Royal Statistical Society to support Joint Biosecurity Centre COVID-19 response
- NDM’s Jenner Institute appoints first Bvlgari Scholars
- NDM New Professors
- Trials of Oxford coronavirus vaccine begin in Kenya
- Oxford ramps up COVID-19 testing capability
- Oxford’s vaccine research and development boosted by donation from Wafic Saïd
- Oxfordshire Young Scientists of the Year 2020
- Oxford University breakthrough on global COVID-19 vaccine
- First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
- Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on azithromycin, 14 December 2020
- National COVID-19 Infections Survey reveals changes to pandemic over time
- Professor Susie Dunachie awarded flagship NIHR career development award
- Oxford University welcomes UK regulatory emergency use authorisation of coronavirus vaccine
- Professor Sir Dave Stuart, FRS FMedSci knighted in New Year's Honours
- National consortium to study threats of new SARS-CoV-2 variants
- Lateral flow devices detect most infectious COVID-19 cases and could allow a safer relaxation of the current lockdown
- Oxford Cancer Centre appoints Professor Tim Elliot as new co-director
- Infectious disease experts estimate that using the NHS COVID-19 contact tracing app averted between 200,000 and 900,000 infections
- Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests
- Tocilizumab reduces deaths in patients hospitalised with COVID-19
- Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer’s disease
- World’s largest clinical trial for COVID-19 treatments expands internationally
- Graduate access programmes now open for 2021 applications
- Professor Sarah Gilbert awarded RSA Albert Medal
- Work for us